Regulatory approval and commercialization for medical devices

A good Medical Device
is not yet a business.

URATIO helps medical device companies take their novel or established device through the clinical evaluation process, select the best claims for market revenue, tie in the available evidence and write the story for your regulatory body.

Surgeons using a medical device in an operating room

What we do

Four ways in

Approach

Operator work, not a slide deck.

Engagements are short, scoped and hands-on. The output is a decision you can act on and the material to execute it — not a recommendation left on the table.

  1. Diagnose

    You present the device, the documentation and the stakeholders involved. What is the issue to be fixed.

  2. Decide

    We decide what is the best option for your device and URATIO creates the outcome needed.

  3. Deploy

    URATIO can assist in submissions and meetings with regulatory authorities for all the does and don’t that come with submissions.

Portrait of Søren Underbjerg, founder of URATIO

Founder

Søren Underbjerg

Ten years with medical devices, 3,5 years as a GP and the rest working as Senior regulatory advisor, with devices in all classes and technologies covering simple syringes to heart valves, and working a lot with Software as Medical Devices companies. URATIO is that experience offered directly, working alongside the founders and developers rather than above them.

Based in Denmark, working with medical companies across Europe.

Start a conversation

Experience

Geographical location of stakeholders, experience across continents in project management and international etiquette.

Footprint

  • Europe

    UK, Germany, France, Belgium, Netherlands, Switzerland, Denmark, Norway, Sweden, Finland

  • Asia

    India, China, Japan

  • Middle East

    Israel, Saudi Arabia

  • North America

    USA

Documents

220+major regulatory documents delivered, 2020–2026

  • Clinical Evaluation Plans (CEP) 86
  • Clinical Evaluation Reports (CER) 74
  • PMCF plans 24
  • Risk management analyses 19
  • PMS plans 17

All as lead author

Expertise & education

  1. 2018 BSc. Medicine, Aalborg University
  2. 2020 Cand. Med. Scient., Medical Market Access, Aalborg University 2020–2026 · Senior regulatory advisor

Standards

  • MDR
  • IVDR
  • ISO 13485
  • ISO 14971
  • ISO 14155
  • MDSAP
  • FDA
  • QMS
  • Regulatory strategy
  • Clinical development
  • Market access EU & US
  • Technical documentation
  • Clinical evaluation
  • Risk management
  • Medical writing
  • Quality management systems
  • 2020–2026 Achievements & global MedTech experience
  • Clinical evaluation expert
  • Regulatory strategy lead
  • Project manager
  • Team lead, clinical development & market access
  • Speaker, 9th EAAR Annual Conference (2025)

Tell me where the product is stuck.

A thirty-minute call is enough to say whether this is work I can help with.